Presentation of Eye Fobrosis Data at ARVO Meeting
Filed with ASX · · 3 pages · English
Earlier from AdAlta
- AdAlta expands partnership with Alfred Hospital
- AdAlta receives Orphan Designation for AD-114
- Positive Pre-clinical Data
- Commercialisation Agreement with Crossbeta Biosciences
- Quarterly Review and Appendix 4C
Later from AdAlta
- Toxicology study and manufacturing update
- AdAlta awarded SIEF grant
- Results of multi-dose toxicology study
- Conference Presentation
- Commercial agreement with XL-protein
Follow AdAlta into a list and get an email when it puts out news.
Follow AdAlta